Garetosmab
Study of Safety and Effects of Garetosmab in Healthy Obese Men and Post-Menopausal Women
Regeneron · Phase 1 · Withdrawn · Enrollment 0
| Arm | Population | Dose | Weeks | Estimand | Weight change |
|---|---|---|---|---|---|
| High Dose | Obesity or overweight | n/r | n/r | n/r | n/r |
| Low Dose | Obesity or overweight | n/r | n/r | n/r | n/r |
| Placebo | Obesity or overweight | n/r | n/r | n/r | n/r |